Tranexamic Acid

Confirm delete?

Tranexamic Acid

Zoom

Cat No: 19193

Biochemicals - More Biochemicals

Tranexamic acid is an inhibitor of fibrinolysis that inhibits the interaction of plasmin with fibrin (IC50 = 3.1 µM in isolated human plasma).{31118} It decreases α-naphthylisothiocyanate (ANIT)-induced increases in the expression of the profibrogenic...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

trans-4-(aminomethyl)-cyclohexanecarboxylic acid

Correlated keywords:

1628783-16-3 AMCHA Amchafibrin Amikapron Anvitoff Bay 3517 BAY3517 CL 65336 CL65336 Cyclocapron Cyclokapron Cyklokapron DV 79 DV79 Exacyl HAKU Haematrix Lysteda TAMCHA Tranol Transamin Transamin G Transamin S Transcam Uguro Xamig Xed Zataranax t-AMCHA trans-Amcha trans-Tranexamic acid naphthyl isothiocyanate CK 19 Timp Col1a 1 Itgb 6 Tgf? 1 2

Product Overview:
Tranexamic acid is an inhibitor of fibrinolysis that inhibits the interaction of plasmin with fibrin (IC50 = 3.1 µM in isolated human plasma).{31118} It decreases α-naphthylisothiocyanate (ANIT)-induced increases in the expression of the profibrogenic genes Timp1 and Col1a1, but not Itgb6, Tgfβ1, or Tgfβ2, and reduces protein levels of cytokeratin 19 (CK19) and type I collagen in the liver after 28 days in a mouse model of chronic bile duct injury.{45512}

Size	25 g
Shipping	room temp.
CAS Number	1197-18-8
Molecular Formula	C₈H₁₅NO₂
SMILES	OC([C@@H]1CC[C@@H](CN)CC1)=O
Molecular Weight	157,2
Formulation	A crystalline solid
Purity	≥95%
Custom Code	2902.11
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.